Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2000, p. 2023-2027, Vol. 44, No. 8
Laboratory of Drug Resistance in Bacteria,
Gunma University School of Medicine, Maebashi,1
Division of Microbial Chemistry, Faculty of Pharmaceutical
Sciences, Chiba University, Chiba,2 and
Research Laboratory, Toyama Chemical Co., Ltd.,
Toyama,3 Japan
Received 8 October 1999/Returned for modification 31 January
2000/Accepted 5 May 2000
In the course of surveying for the carbapenem-hydrolyzing
metallo-
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Amino Acid Substitutions in a Variant of
IMP-1 Metallo-
-Lactamase
-lactamase gene blaIMP in pathogenic
bacteria by the PCR method, we detected a gene encoding a variant
metallo-
-lactamase, designated IMP-3, which differed from IMP-1 by
having low hydrolyzing activity for penicillins and carbapenems. PCR
product direct sequencing of a 2.2-kb segment revealed that the gene
blaIMP-3 was located on a cassette inserted
within a class I integron in the pMS390 plasmid. The 741-bp nucleotide
sequence of blaIMP-3 was identical to that of
blaIMP-1, except for seven base substitutions.
Among these were two, at nucleotide positions 314 and 640, which caused amino acid alterations. Hybrid bla genes were constructed
from blaIMP-3 and
blaIMP-1 by recombinant DNA techniques, and
-lactamases encoded by these genes were compared with those of the
parents IMP-3 and IMP-1 under the same experimental conditions. The
kinetic parameters indicated that the inefficient hydrolysis of
benzylpenicillin, ampicillin, imipenem, and ceftazidime by IMP-3 was
due to the substitution of glycine for serine at amino acid residue 196 in the mature enzyme. This alteration corresponded to the presence of
guanine instead of an adenine at nucleotide position 640 of the
blaIMP-3 gene. This indicated that extension of
the substrate profile in the metallo-
-lactamase IMP-1 compared to
IMP-3 is the result of a one-step single-base mutation, suggesting that the gene blaIMP-3 is an ancestor of
blaIMP-1.
*
Corresponding author. Mailing address: Laboratory of
Drug Resistance in Bacteria, Gunma University School of Medicine,
3-39-22, Showa-Machi, Maebashi, 371-8511, Japan. Phone: 81-27-220-8087. Fax: 81-27-220-8088. E-mail:
siyobe{at}akagi.sb.gunma-u.ac.jp.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |